Super-pulsed Diode Laser in the Therapy of Inferior Alveolar Nerve Paresthesia After Mandibular Third Molar Extraction: A Case Report.

Oral paresthesia occurs when one of the nerves in the region is injured, usually the inferior alveolar and/or lingual nerve, after dental procedures such as the extraction of lower third molars. The objective of this study was to describe the case of a patient who received photobiomodulation (PBM) therapy for paresthesia of the inferior alveolar nerve (IAN) caused by the extraction of mandibular third molars. The protocol used involved a super-pulsed diode laser with dual wavelengths of 810 nm and 980 nm, 1 W, 60 seconds, 12.

sp. nov. (Bothriocephalidae Blanchard, 1849), a cestode parasite of the shorthead lizardfish (Synodontidae) from the Pacific coast of Costa Rica.

A new species of bothriocephalid cestode in the genus is described from the intestine of the shorthead lizardfish from the north Pacific coast of Costa Rica. The new species is described based on an integrative taxonomic approach that includes the use of light and scanning electron microscopy, 28S rDNA sequencing, and phylogenetic analysis. sp.

Geographic genetic variation in the Coral Hawkfish, (Cirrhitidae), in relation to biogeographic barriers across the Tropical Indo-Pacific.

The Tropical Indo-Pacific (TIP) includes about two thirds of the world's tropical oceans and harbors an enormous number of marine species. The distributions of those species within the region is affected by habitat discontinuities and oceanographic features. As well as many smaller ones, the TIP contains seven large recognized biogeographic barriers that separate the Red Sea and Indian Ocean, the Indian from the Pacific Ocean, the central and eastern Pacific, the Hawaiian archipelago, the Marquesas and Easter Islands.

A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.

Background: Dienogest (DNG) 2 mg/ethinylestradiol (EE) 0.02 mg is the first low-dose combined oral contraceptive (COC) with a prolonged-release formulation that allows stable plasma concentrations and has high contraceptive efficacy (Pearl index: 0.2).